PHASE II STUDY OF THE COMBINATION OF BEVACIZUMAB (RHUMAB VEGF) AND OXALIPLATIN PLUS CAPECITABINE (XELOX) IN PATIENTS WITH ADVANCED COLORECTAL CANCER

被引：0
|
作者：
Sarmiento, R. [1 ]
Frustaci, S. [2 ]
Torino, F. [3 ]
Ravaioli, A. [4 ]
Mattioli, R. [5 ]
Gebbia, V. [6 ]
Veri, A. [3 ]
Gasparini, G. [7 ]
机构：
[1] San Filippo Neri, Oncol, Rome, Italy
[2] Ctr Riferimento Oncol, Med Oncol B, I-33081 Aviano, Italy
[3] Aco San Filippo Neri, Med Oncol B, Rome, Italy
[4] Osped Infermi, Rimini, Italy
[5] Osped Santa Croce, Fano, Italy
[6] Osped Rinuniti Alta Specializzaz Maddalena, Palermo, Italy
[7] San Filippo Neri Hosp, Rome, Italy
来源：
ANNALS OF ONCOLOGY | 2008年 / 19卷
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：144 / 144
页数：1
相关论文
共 50 条
  • [1] Phase II study of the combination of bevacizumab (Rhumab VEGF) and oxaliplatin plus capecitabine (Xelox) in patients with advanced colorectal cancer
    Sarmiento, R.
    Frustaci, S.
    Bonadonna, A.
    Ravaioli, A.
    Oliviero, G.
    Mattioli, R.
    Tarnburrano, T.
    Gebbia, V
    Agueli, R.
    Torino, F.
    Lo Noce, V
    Veri, A.
    Gasparini, G.
    [J]. ANNALS OF ONCOLOGY, 2008, 19 : 85 - 86
  • [2] A phase II study of the combination of bevacizumab (rhuMAb VEGF, BV) and oxaliplatin (O), plus capecitabine (C) in patients (Pts) with advanced colorectal cancer (ACRC)
    Veri, A.
    Ravaioli, A.
    Oliviero, G.
    Sarmiento, R.
    Torino, F.
    Frustaci, S.
    Buonadonna, A.
    Mattioli, R.
    Lippe, C.
    Gebbia, V.
    Agueli, R.
    Lonoce, V. A.
    Gasparini, G.
    [J]. ANNALS OF ONCOLOGY, 2007, 18 : 7 - 7
  • [3] Capecitabine and oxaliplatin (XELOX) in combination with bevacizumab in the treatment of metastatic colorectal cancer: results of a phase II trial
    Bendell, J.
    Yu, D.
    Hurwitz, H.
    Morse, M.
    Blobe, G.
    Gockerman, J.
    Odogwu, L.
    Mahon, M.
    Truax, R.
    Fernando, N.
    [J]. EJC SUPPLEMENTS, 2005, 3 (02): : 189 - 189
  • [4] Chronomodulated administration of oxaliplatin plus capecitabine (XELOX) as first line chemotherapy in advanced colorectal cancer patients:: phase II study
    Santini, Daniele
    Vincenzi, Bruno
    Schiavon, Gaia
    Di Seri, Marisa
    Virzi, Vladimir
    Spalletta, Bruno
    Caricato, Marco
    Coppola, Roberto
    Tonini, Giuseppe
    [J]. CANCER CHEMOTHERAPY AND PHARMACOLOGY, 2007, 59 (05) : 613 - 620
  • [5] Chronomodulated administration of oxaliplatin plus capecitabine (XELOX) as first line chemotherapy in advanced colorectal cancer patients: phase II study
    Daniele Santini
    Bruno Vincenzi
    Gaia Schiavon
    Marisa Di Seri
    Vladimir Virzí
    Bruno Spalletta
    Marco Caricato
    Roberto Coppola
    Giuseppe Tonini
    [J]. Cancer Chemotherapy and Pharmacology, 2007, 59 : 613 - 620
  • [6] Phase I/II Study of Capecitabine Plus Oxaliplatin (XELOX) Plus Bevacizumab As First-line Therapy in Japanese Patients with Metastatic Colorectal Cancer
    Doi, Toshihiko
    Boku, Narikazu
    Kato, Ken
    Komatsu, Yoshito
    Yamaguchi, Kensei
    Muro, Kei
    Hamamoto, Yasuo
    Sato, Atsushi
    Koizumi, Wasaburo
    Mizunuma, Nobuyuki
    Takiuchi, Hiroya
    [J]. JAPANESE JOURNAL OF CLINICAL ONCOLOGY, 2010, 40 (10) : 913 - 920
  • [7] Phase II study of short-course capecitabine plus oxaliplatin (XELOX) followed by maintenance capecitabine in advanced colorectal cancer: XelQuali study
    Waddell, T.
    Gollins, S.
    Soe, W.
    Valle, J.
    Allen, J.
    Bentley, D.
    Morris, J.
    Lloyd, A.
    Swindell, R.
    Taylor, M. B.
    Saunders, M. P.
    [J]. CANCER CHEMOTHERAPY AND PHARMACOLOGY, 2011, 67 (05) : 1111 - 1117
  • [8] Phase II study of short-course capecitabine plus oxaliplatin (XELOX) followed by maintenance capecitabine in advanced colorectal cancer: XelQuali study
    T. Waddell
    S. Gollins
    W. Soe
    J. Valle
    J. Allen
    D. Bentley
    J. Morris
    A. Lloyd
    R. Swindell
    M. B. Taylor
    M. P. Saunders
    [J]. Cancer Chemotherapy and Pharmacology, 2011, 67 : 1111 - 1117
  • [9] OXALIPLATIN AND CAPECITABINE (XELOX) PLUS BEVACIZUMAB (BEVA) FOR ELDERLY PATIENTS (PTS) WITH METASTATIC COLORECTAL CANCER (mCRC): BOXE, A PHASE II TRIAL
    Rosati, Gerardo
    Cordio, Stefano
    Leo, Silvana
    Daniele, Bruno
    Butera, Alfredo
    [J]. ANNALS OF ONCOLOGY, 2011, 22 : v104 - v104
  • [10] Capecitabine (X) following short-course capecitabine plus oxaliplatin (XELOX) in advanced colorectal cancer (CRC): Phase II XelQuali study
    Soe, W.
    Gollins, S.
    Waddell, T.
    Valle, J. W.
    Allen, J.
    Bentley, D.
    Morris, J.
    Lloyd, A.
    Swindell, R.
    Saunders, M. P.
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2008, 26 (15)
12345